Search Results - "Serna, Juliana"

Refine Results
  1. 1

    Cholesterol grafted cationic lipopolymers: Potential siRNA carriers for selective chronic myeloid leukemia therapy by Remant, KC, Thapa, Bindu, Valencia‐Serna, Juliana, Domun, Suraj S., Dimitroff, Cailean, Jiang, Xiaoyan, Uludağ, Hasan

    “…Synthetic siRNA technology has emerged as a promising approach for molecular therapy of cancer but, despite its potential for post‐transcriptional gene…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Preparación de muestras sólidas para el análisis por fluorescencia de rayos X: una revisión by Pérez Diaz, Linda Alejandra, Serna Saiz, Juliana, Torres Quezada, Henry

    Published in Revista colombiana de química (20-09-2024)
    “…La fluorescencia de rayos X (XRF, por sus siglas en inglés) permite realizar análisis multielementales en diversas matrices sólidas, incluidos polvos y granos…”
    Get full text
    Journal Article
  4. 4

    Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia by Landry, Breanne, Valencia-Serna, Juliana, Gul-Uludag, Hilal, Jiang, Xiaoyan, Janowska-Wieczorek, Anna, Brandwein, Joseph, Uludag, Hasan

    Published in Molecular therapy. Nucleic acids (01-05-2015)
    “…Leukemias arise from genetic alterations in normal hematopoietic stem or progenitor cells, leading to impaired regulation of proliferation, differentiation,…”
    Get full text
    Journal Article
  5. 5

    Picocyanobacteria aggregation as a response to predation pressure: direct contact is not necessary by Ospina-Serna, Juliana, Huber, Paula, Odriozola, Mariana, Fermani, Paulina, Unrein, Fernando

    Published in FEMS microbiology ecology (02-10-2020)
    “…Picocyanobacteria (cells <2 µm) can be found either as single-cells (Pcy) or embedded in a mucilaginous sheath as microcolonies or colonies (CPcy). It has been…”
    Get full text
    Journal Article
  6. 6

    siRNA/lipopolymer nanoparticles to arrest growth of chronic myeloid leukemia cells in vitro and in vivo by Valencia-Serna, Juliana, Aliabadi, Hamidreza M., Manfrin, Adam, Mohseni, Mahsa, Jiang, Xiaoyan, Uludag, Hasan

    “…[Display omitted] Therapies for the treatment of Chronic Myeloid Leukemia and other leukemias are still limited for patients at advanced stages, which allow…”
    Get full text
    Journal Article
  7. 7

    Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic options by Meenakshi Sundaram, Daniel Nisakar, Jiang, Xiaoyan, Brandwein, Joseph M., Valencia-Serna, Juliana, Remant, K.C., Uludağ, Hasan

    Published in Drug discovery today (01-07-2019)
    “…•Bcr-Abl oncogene is the hallmark of chronic myeloid leukemia.•Leukemic cells can readily resist against tyrosine kinase inhibitor drugs.•Understanding…”
    Get full text
    Journal Article
  8. 8

    siRNA-mediated BCR-ABL silencing in primary chronic myeloid leukemia cells using lipopolymers by Valencia-Serna, Juliana, Kucharski, Cezary, Chen, Min, KC, Remant, Jiang, Xiaoyan, Brandwein, Joseph, Uludağ, Hasan

    Published in Journal of controlled release (28-09-2019)
    “…Despite development of effective tyrosine kinase inhibitors for treatment of chronic myeloid leukemia (CML), some patients do not effectively respond to the…”
    Get full text
    Journal Article
  9. 9

    An ontology for the design of emulsion-based cosmetic products: Development and applications by Serna, Juliana, Gabriel, Alex, Boly, Vincent, Falk, Véronique, Narváez-Rincón, Paulo C.

    Published in Computers & chemical engineering (01-05-2023)
    “…•OntoCosmetic is an ontology for the design of emulsion-based cosmetic products.•It contains specific concepts and their interrelations such as: cosmetic…”
    Get full text
    Journal Article
  10. 10

    A Methodology for Emulsion Design Based on Emulsion Science and Expert Knowledge. Part 1: Conceptual Approach by Serna, Juliana, Narváez Rincón, Paulo C, Falk, Véronique, Boly, Vincent, Camargo, Mauricio

    “…Formulated emulsions have a high commercial value due to their multiple applications in several product sectors such as cosmetics, nutrition, medicine, and…”
    Get full text
    Journal Article
  11. 11

    Methodology for Emulsion Design Based on Emulsion Science and Expert Knowledge. Part 2: An Application in the Cosmetics Sector by Serna, Juliana, Narváez Rincón, Paulo C, Falk, Véronique, Boly, Vincent, Camargo, Mauricio

    “…The design of microstructured chemical products such as emulsions is not a simple task because they are complex systems in which their components, structures,…”
    Get full text
    Journal Article
  12. 12

    Triggers for chemical product design: A systematic literature review by Rivera Gil, Jose Luis, Serna, Juliana, Arrieta‐Escobar, Javier A., Narváez Rincón, Paulo César, Boly, Vincent, Falk, Veronique

    Published in AIChE journal (01-04-2022)
    “…The product design project is a complex problem because objectives and constraints must be considered simultaneously, the sustainability context is highly…”
    Get full text
    Journal Article
  13. 13

    Nucleic acid combinations: A new frontier for cancer treatment by K.C., Remant Bahadur, Thapa, Bindu, Valencia-Serna, Juliana, Aliabadi, Hamidreza Montezari, Uludağ, Hasan

    Published in Journal of controlled release (28-06-2017)
    “…The emerging molecular understanding of cancer cell behavior is leading to increasing possibilities to control unchecked cell growth and metastasis. On the…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Investigating siRNA delivery to chronic myeloid leukemia K562 cells with lipophilic polymers for therapeutic BCR-ABL down-regulation by Valencia-Serna, Juliana, Gul-Uludağ, Hilal, Mahdipoor, Parvin, Jiang, Xiaoyan, Uludağ, Hasan

    Published in Journal of controlled release (10-12-2013)
    “…RNAi represents a new alternative for treatment of chronic myeloid leukemia (CML) to overcome the difficulties of current drug treatments such as the acquired…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Current attempts to implement siRNA-based RNAi in leukemia models by Uludağ, Hasan, Landry, Breanne, Valencia-Serna, Juliana, Remant-Bahadur, K.C., Meneksedağ-Erol, Deniz

    Published in Drug discovery today (01-09-2016)
    “…•Application of RNAi technology as a therapeutic strategy for leukemia treatment.•Critical considerations in nonviral delivery of RNAi reagents.•Recent…”
    Get full text
    Journal Article
  18. 18

    Multi-criteria decision analysis for the selection of sustainable chemical process routes during early design stages by Serna, Juliana, Díaz Martinez, Esneider N., Narváez Rincón, Paulo C., Camargo, Mauricio, Gálvez, Daniel, Orjuela, ÿlvaro

    Published in Chemical engineering research & design (01-09-2016)
    “…[Display omitted] ⿢A methodology to assess sustainability of chemical process routes is proposed.⿢The methodology provides a metric to discern different…”
    Get full text
    Journal Article
  19. 19

    Polymeric nanoparticle-mediated silencing of CD44 receptor in CD34+ acute myeloid leukemia cells by Gul-Uludağ, Hilal, Valencia-Serna, Juliana, Kucharski, Cezary, Marquez-Curtis, Leah A, Jiang, Xiaoyan, Larratt, Loree, Janowska-Wieczorek, Anna, Uludağ, Hasan

    Published in Leukemia research (01-11-2014)
    “…Highlights • Polymeric nanoparticle-mediated CD44 silencing in CD34+ AML cells was efficient. • Surface CD44 silencing lead to induction of apoptosis. • CD44…”
    Get full text
    Journal Article
  20. 20

    Pulsed Ultrasound Enhances Nanoparticle Penetration into Breast Cancer Spheroids by Grainger, Stephanie J, Serna, Juliana Valencia, Sunny, Steffi, Zhou, Yun, Deng, Cheri X, El-Sayed, Mohamed E. H

    Published in Molecular pharmaceutics (06-12-2010)
    “…Effective treatment of solid tumors requires homogeneous distribution of anticancer drugs within the entire tumor volume to deliver lethal concentrations to…”
    Get full text
    Journal Article